Danaher Co. (NYSE:DHR) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC lowered its position in Danaher Co. (NYSE:DHR - Free Report) by 1.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,042,760 shares of the conglomerate's stock after selling 141,926 shares during the quarter. Geode Capital Management LLC owned about 1.81% of Danaher worth $3,611,430,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Diversified Trust Co raised its position in Danaher by 75.4% in the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate's stock valued at $1,090,000 after purchasing an additional 1,874 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in shares of Danaher by 1.2% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 196,910 shares of the conglomerate's stock valued at $49,198,000 after acquiring an additional 2,395 shares during the last quarter. Great Valley Advisor Group Inc. lifted its holdings in shares of Danaher by 11.4% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 1,585 shares of the conglomerate's stock worth $396,000 after acquiring an additional 162 shares during the last quarter. Ferguson Wellman Capital Management Inc. increased its holdings in Danaher by 17.5% in the 2nd quarter. Ferguson Wellman Capital Management Inc. now owns 1,785 shares of the conglomerate's stock valued at $446,000 after purchasing an additional 266 shares during the last quarter. Finally, ORG Partners LLC increased its holdings in Danaher by 7,633.3% in the 2nd quarter. ORG Partners LLC now owns 464 shares of the conglomerate's stock valued at $114,000 after purchasing an additional 458 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

Danaher stock traded down $1.57 during midday trading on Tuesday, reaching $234.34. The company's stock had a trading volume of 2,688,811 shares, compared to its average volume of 2,778,684. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a fifty-two week low of $217.96 and a fifty-two week high of $281.70. The firm has a market capitalization of $169.26 billion, a PE ratio of 44.72, a P/E/G ratio of 4.23 and a beta of 0.83. The stock's 50 day simple moving average is $249.91 and its 200 day simple moving average is $258.14.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. During the same quarter in the prior year, the firm posted $2.02 EPS. The company's revenue was up 3.1% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher's dividend payout ratio is presently 20.61%.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. TD Cowen lifted their price objective on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price objective for the company in a research note on Thursday, October 31st. Stephens reiterated an "overweight" rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Barclays dropped their price target on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 23rd. Finally, Robert W. Baird reduced their price objective on Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.